ArticleFrontiers in oncology2025

Clinical outcomes of DNA-damaging agents and DNA damage response inhibitors combinations in cancer: a data-driven review.

Rick Fontenot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.